2023 By Nugen December 19, 2023 0 Comments NuGen Medical Signs 5-year Distribution Agreement for InsuJet™ with Verrue Consulting Group in Belgium NuGen Medical Signs 5-year Distribution Agreement for InsuJet™ with Verrue Consulting Group in Belgium December 19th, 2023 – Toronto, Ontario – NuGen Medical Devices Inc. (TSXV: NGMD) (the “Company” or “NuGen“) a leading developer »
2023 By Nugen December 14, 2023 0 Comments NuGen Medical Signs 5-year Distribution Agreement for InsuJet™ with Advance Medical Life Co. NuGen Medical Signs 5-year Distribution Agreement for InsuJet™ with Advance Medical Life Co. December 14th, 2023 – Toronto, Ontario – NuGen Medical Devices Inc. (TSXV: NGMD) (the “Company” or “NuGen“) a leading developer of needle-free devices »
2023 By Nugen November 13, 2023 0 Comments InsuJet™ Registered as a Medical Device in Mexico InsuJet™ Registered as a Medical Device in Mexico Second Bulk Sale for InsuJet™ Now Paid in Full November 13th, 2023 – Toronto, Ontario – NuGen Medical Devices Inc. (TSXV: NGMD) (the “Company” or “NuGen“) »
2023 By Nugen November 7, 2023 0 Comments Diabetic Lifestyle Subscription Business Launched on Shopify as NuGen’s B2C Business Vertical Diabetic Lifestyle Subscription Business Launched on Shopify as NuGen’s B2C Business Vertical www.insujet.com – a diabetic e-commerce store November 7th, 2023 – Toronto, Ontario – NuGen Medical Devices Inc. (TSXV: NGMD) (the “Company” or “NuGen»
2023 By Nugen November 2, 2023 0 Comments MedTech Industry Leader Ian Heynen Commences CEO role at NuGen MedTech Industry Leader Ian Heynen Commences CEO role at NuGen November 2nd, 2023 – Toronto, Ontario – NuGen Medical Devices Inc. (TSXV: NGMD) (the “Company” or “NuGen“) a leading developer of needle-free devices to »
2023 By Nugen October 12, 2023 0 Comments NuGen Medical Appoints Industry Leader Ian Heynen as CEO NuGen Medical Appoints Industry Leader Ian Heynen as CEO October 12th, 2023 – Toronto, Ontario – NuGen Medical Devices Inc. (TSXV: NGMD) (the “Company” or “NuGen“) a leading developer of needle free devices to »
2023 By Nugen October 10, 2023 0 Comments Semaglutide – Ozempic® is Chemically Stable when Administered using Nugen’s needle free InsuJet™ Device Semaglutide – Ozempic® is Chemically Stable when Administered using Nugen’s needle free InsuJet™ Device October 10th, 2023, Toronto, Ontario – NuGen Medical Devices Inc. (TSXV: NGMD) (the “Company” or “NuGen“) a leading developer of »
2023 By Nugen September 20, 2023 0 Comments NuGen Medical Completes Delivery and First Sale of 500 InsuJet™ Devices and Consumables in Romania NuGen Medical Completes Delivery and First Sale of 500 InsuJet™ Devices and Consumables in Romania Toronto, Ontario – September 20th, 2023 – NuGen Medical Devices Inc. (TSXV: NGMD) (the “Company” or “NuGen“) is pleased to report »
2023 By Nugen September 11, 2023 0 Comments NuGen Receives $1.3M Through Early Option and Warrant Exercise NuGen Receives $1.3M Through Early Option and Warrant Exercise September 11th, 2023 – Toronto, Ontario – NuGen Medical Devices Inc. (TSXV: NGMD) (the “Company” or “NuGen“) is pleased to report it has received $1,302,000 through »
2023 By Nugen September 5, 2023 0 Comments NuGen Announces Participation at the 2023 Kinvestor Days Virtual Conference Tech Day NuGen Announces Participation at the 2023 Kinvestor Days Virtual Conference Tech Day September 5th, 2023 – Toronto, Ontario – NuGen Medical Devices Inc. (TSXV: NGMD) (the “Company” or “NuGen”), is pleased to announce that »
